Chojdak-Łukasiewicz, Justyna https://orcid.org/0000-0002-0777-4565
Kułakowska, Alina
Tarasiuk, Joanna
Kapica-Topczewska, Katarzyna
Siuda, Joanna
Galus, Weronika
Patalong-Ogiewa, Maja
Kaczmarczyk, Aleksandra
Lasek-Bal, Anetta
Krzystanek, Ewa
Stęposz, Arkadiusz
Karuga, Aleksandra
Jasińska, Elżbieta
Gołuch, Katarzyna
Brola, Waldemar
Odzimek, Martyna
Słowik, Agnieszka
Kaczówka, Klaudia
Wnuk, Marcin
Marona, Monika
Rejdak, Konrad
Jamroz-Wiśniewska, Anna
Stasiołek, Mariusz
Bielecki, Bartosz
Świderek-Matysiak, Mariola
Siger, Małgorzata
Głąbiński, Andrzej
Milewska-Jędrzejczak, Marta
Łabuz-Roszak, Beata
Gardzińska, Małgorzata
Sakowska, Maja
Bartosik-Psujek, Halina
Rościszewska-Żukowska, Iwona
Popiel, Małgorzata
Rudnicka-Czerwiec, Julia
Potemkowski, Andrzej
Adamczyk-Sowa, Monika
Kubicka-Bączyk, Katarzyna
Niedziela, Natalia
Kołtuniuk, Aleksandra
Budrewicz, Sławomir
Pokryszko-Dragan, Anna
Article History
Received: 11 July 2025
Accepted: 12 August 2025
First Online: 30 September 2025
Declarations
:
: Justyna Chojdak-Łukasiewicz has participated as a speaker at meetings sponsored by Biogen, Merck, Novartis, Roche. Anna Pokryszko-Dragan served as a speaker for Biogen, Bristol Myers Squibb, Merck, Novartis, Roche. Alina Kułakowska has received compensation for speaking and consulting services from Biogen, Bayer, Novartis, Roche, Merck, Teva, Bristol Myers Squibb, Janssen-Cilag, and Sanofi Genzyme. Katarzyna Kapica-Topczewska has participated as a speaker at meetings sponsored by Novartis, Biogen, and AstraZeneca. Waldemar Brola has been involved in scientific advisory boards for Biogen, Roche, Novartis, and Merck and has received honoraria for lecturing from Biogen, Merck, Novartis, Sanofi Genzyme, and Roche. Ewa Krzystanek has received compensation for speaking and consulting services from Biogen, Bayer, Novartis, Roche, Merck, Teva, TG Therapeutics, and Sanofi-Genzyme. None of these are relevant to the present manuscript. The other authors declare no conflict of interest.
: The study was conducted in accordance with the Helsinki declaration; the protocol of the project had been approved by the Bioethical Committee of Wroclaw Medical University (opinion No 164/2023). Written informed consent was obtained from all individual participants, prior to their inclusion in the study.